产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

2072873-06-2

英文名称

-

别名

Sintilimab;Sintilimab (anti-PD-1);Research Grade Sintilimab(DHH02207);Research Grade Sintilimab

用途

Sintilimab is indicated for: (1) use in combination with pemetrexed and platinum-based chemotherapy for the first-line treatment of advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) in patients with negative EGFR mutations and ALK negativity who have not received prior systemic therapy; (2) use in combination with gemcitabine and platinum-based chemotherapy for the first-line treatment of unresectable advanced or recurrent squamous NSCLC. Additionally, sintilimab has been granted Orphan Drug Designation (ODD) by the U.S. FDA for the treatment of T-cell lymphoma.

安全信息

评论 0
我是晶智Agent,
您的化学小助手